Newport Trust Company’s Trueblue TBI Stock Holding History

Newport Trust Company’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-56,087	Closed	-$1.54M	–	50
2017 Q4	$1.54M	Buy	+56,087	New	+$1.49M	﹤0.01%	47

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Newport Trust Company's TBI Position: Q1 2018 in Review

Newport Trust Company sold out of Trueblue (TBI) in Q1 2018, closing a stake of 56,087 shares — an estimated $1.54M sold.

Newport Trust Company first reported a position in TBI in Q4 2017 and held it in 1 quarter. The position peaked at $1.54M in Q4 2017. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.

Newport Trust Company reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
Newport Trust Company sold 56,087 Trueblue shares in Q1 2018, an estimated $1.54M.
Newport Trust Company first reported a position in Trueblue in Q4 2017 and held it in 1 quarter.
Newport Trust Company's Trueblue position peaked at $1.54M in Q4 2017.
196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.

Based on Newport Trust Company's 13F filing for Q1 2018, filed 4 May 2018.